The vaccine is administered using a needle-free applicator as opposed to traditional syringes

The Union Health Ministry is learnt to have given the go ahead to initiate the preparatory work for the introduction of the indigenously developed ZyCoV-D. 

Zydus Cadila’s three-dose Covid vaccine ZyCoV-D is set to be included in the national anti-coronavirus inoculation programme this month with the Centre placing a purchase order with the Ahmedabad-based firm for one crore doses, official sources said on Sunday. The Union Health Ministry is learnt

ZyCoV-D, the world’s first plasmid DNA vaccine, will be administered using a needle-free applicator

ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus. It is also the first covid vaccine that is needle-free and administered using PharmaJet, a needle-free applicator to ensure painless intradermal vaccine delivery which also leads to a significant reduction in any kind of major side effects.

Zydus Cadila's three-dose Covid vaccine ZyCoV-D is set to be included in the national anti-coronavirus inoculation programme this month with the Centre placing a purchase order with the Ahmedabad-based firm for one crore doses, official sources said on Sunday. The Union Health Ministry is learnt to have given the go ahead to initiate the preparatory […]

The three doses of ZyCoV-D are to be administered 28 days apart, with each dose comprising a shot in both arms. ZyCoV-D received emergency use authorisation from the drug regulator on August 20.

ZyCoV-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above.

A group of researchers from Maccabi Healthcare Services performed a retrospective cohort study to determine vaccine effectiveness of a third dose.

New Delhi: Drug firm Zydus Cadila on Monday said it has received an order to supply one crore doses of its COVID-19 vaccine, ZyCoV-D, to the Indian

Needle-free vaccine to be available in November; Deliberations on to decide its use among children New Delhi: Days after Prime Minister Narendra Modi exhorted officials to scale up door-to-door COVID vaccination to achieve full adult inoculation target by the year-end, the Health Ministry has ordered one crore doses of the world’s first and India’s indigenously...

ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the COVID-19 virus, Zydus Cadila said.

Cadila Healthcare Ltd will supply 1 crore doses of ZyCoV-D, the world’s first Plasmid DNA vaccine to the Government of India.

The country's drugs regulator, DGCI, had approved Zydus Cadila's ZyCoV-D vaccine for emergency use on August 20.

ZyCoV-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above

ZyCoV-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above.

Zydus Cadila’s three-dose Covid vaccine ZyCoV-D is set to be included in the national anti-coronavirus inoculation programme this month with the Centre placing a purchase order with the Ahmedabad-based firm for one crore doses, official sources said on Sunday.

ZyCoV-D is the first needle-free Covid vaccine cleared by India’s drug regulator for inoculation of those aged 12 years and above.

The three-dose Covid vaccine was cleared by India’s drug regulator for inoculation of those aged 12 years and above.

Uttar Pradesh has administered the highest number of first and second doses

The indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received emergency use authorisation from the drug regulator on August 20.

The needle-free vaccine has shown efficacy of 66.66%

ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the COVID-19 virus.

The needle-free applicator will be sold separately for Rs 93 per unit.

The Union government has placed order to buy one crore doses of the three-dose 'ZycoV-D' vaccine, official sources informed on Sunday.

ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus

High recoveries and a low number of fresh COVID-19 cases have reduced the active caseload in Uttar Pradesh to 85, while the percentage of active cases as against the total confirmed cases in the state is 0.01 per cent. Signaling control over the second wave of the COVID-19 pandemic, out of the 75

In the last 24 hours, India registered 11,451 new Covid-19 cases and 266 deaths, the Union Health Ministry said on Monday.

In the last 24 hours, India registered 11,451 new Covid-19 cases and 266 deaths

More than 23 lakh (23,84,096) vaccine doses were administered in the last 24 hours.

The Health Ministry stated that the country also recorded 526 coronavirus-related deaths and 12,432 recoveries in the last 24 hours.

India reported a single-day rise of 10,853 new COVID-19 cases, according to Union Health Ministry's data this morning. During the same period, 526 Covid-related deaths were reported, significantly higher than yesterday when 392 deaths were recorded

One new case of COVID-19 has been reported in Northland today and is the third reported since yesterday afternoon.

The country’s toll rose to 4,61,057 after 266 were deaths recorded in the last 24 hours.

A recent study reports the immunogenicity and safety of BNT162b2 and CoronaVac as the third dose in CoronaVac-immunized adults.

 The US has been hit the worst affected followed by India and Brazil.

The toll increased to 4,61,389 after 332 people died of the disease in the last 24 hours.

The death toll has climbed to 4,60,791 with 526 more fatalities, according to the data updated at 8 am.

New Delhi, Nov 8 (IANS): The Centre has finalised the pricing for ZyCoV-D Covid vaccine with manufacturer Zydus Cadilla, at Rs 265 per dose and the needle-free applicator will cost Rs 93 per dose excluding GST. It has also placed an order of one crore vaccine doses for world's first plasmid DNA vaccine.

The Centre has finalised the pricing for ZyCoV-D Covid vaccine with manufacturer Zydus Cadilla, at Rs 265 per dose and the needle-free applicator will cost Rs 93 per dose excluding GST.

The country registered 392 fatalities in the past day.

ZyCoV-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above